These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 2937776)

  • 21. Fluoxetine and two other serotonin uptake inhibitors without affinity for neuronal receptors.
    Wong DT; Bymaster FP; Reid LR; Threlkeld PG
    Biochem Pharmacol; 1983 Apr; 32(7):1287-93. PubMed ID: 6303355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Proserotoninergic agents and depression (author's transl)].
    Uzan A
    Encephale; 1982; 8(2):273-89. PubMed ID: 6286277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alaproclate a novel antidepressant? A biochemical and clinical comparison with zimeldine.
    Aberg-Wistedt A; Alvariza M; Bertilsson L; Malmgren R; Wachtmeister H
    Acta Psychiatr Scand; 1985 Mar; 71(3):256-68. PubMed ID: 2580422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolonged treatment with the specific 5-HT-uptake inhibitor citalopram: effect on dopaminergic and serotonergic functions.
    Arnt J; Hyttel J; Overø KF
    Pol J Pharmacol Pharm; 1984; 36(2-3):221-30. PubMed ID: 6591152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A functional-dimensional approach to depression: serotonin deficiency as a target syndrome in a comparison of 5-hydroxytryptophan and fluvoxamine.
    Pöldinger W; Calanchini B; Schwarz W
    Psychopathology; 1991; 24(2):53-81. PubMed ID: 1909444
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paroxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness.
    Dechant KL; Clissold SP
    Drugs; 1991 Feb; 41(2):225-53. PubMed ID: 1709852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluoxetine: prescribing guidelines for the newest antidepressant.
    Pary R; Tobias C; Lippmann S
    South Med J; 1989 Aug; 82(8):1005-9. PubMed ID: 2669150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 5-Hydroxytryptamine uptake inhibitors antagonize the antireserpine effects of noradrenaline uptake inhibitors.
    Maj J; Rogóz Z; Skuza G
    J Pharm Pharmacol; 1983 Feb; 35(2):128-9. PubMed ID: 6131985
    [No Abstract]   [Full Text] [Related]  

  • 29. The benefits and risks of 5-HT uptake inhibitors in depression.
    Montgomery SA
    Br J Psychiatry Suppl; 1988 Sep; (3):7-10. PubMed ID: 2471570
    [No Abstract]   [Full Text] [Related]  

  • 30. A comparison of trazodone and fluoxetine: implications for a serotonergic mechanism of antidepressant action.
    Marek GJ; McDougle CJ; Price LH; Seiden LS
    Psychopharmacology (Berl); 1992; 109(1-2):2-11. PubMed ID: 1365657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antidepressants and serotonin neurons of the raphe.
    Constantinidis J; Dick P; Tissot R
    Neuropsychobiology; 1981; 7(3):113-21. PubMed ID: 6785659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Current biochemical hypotheses of endogenous depression].
    Riederer P; Beckmann H; Brücke T
    Wien Klin Wochenschr; 1985 Feb; 97(4):190-6. PubMed ID: 2580396
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serotonin activity in psychotic (delusional) major depression.
    Schatzberg AF; Rothschild AJ
    J Clin Psychiatry; 1992 Oct; 53 Suppl():52-5. PubMed ID: 1429484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The relationship of serotonin to depression in Parkinson's disease.
    Mayeux R; Stern Y; Sano M; Williams JB; Cote LJ
    Mov Disord; 1988; 3(3):237-44. PubMed ID: 2461509
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dissociation kinetics of [3H]paroxetine binding to rat brain consistent with a single-site model of the antidepressant binding/5-hydroxytryptamine uptake site.
    Marcusson J; Eriksson K
    J Neurochem; 1988 Nov; 51(5):1477-81. PubMed ID: 2971784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of selective 5-hydroxytryptamine uptake inhibitors on 5-methoxy-N,N-dimethyltryptamine-induced ejaculation in the rat.
    Rényi L
    Br J Pharmacol; 1986 Apr; 87(4):639-48. PubMed ID: 2939912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. No crossover reactions to citalopram or paroxetine among patients hypersensitive to zimeldine.
    Bengtsson BO; Lundmark J; Wålinder J
    Br J Psychiatry; 1991 Jun; 158():853-5. PubMed ID: 1831396
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhancement of imipramine-induced rat brain beta-adrenoreceptor desensitization by subacute co-administration of trazodone, zimelidine, quipazine or 5-hydroxytryptophan.
    Alhaider AA; Mustafa AA
    Psychopharmacology (Berl); 1991; 103(3):351-6. PubMed ID: 1647538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacology of serotonin uptake inhibitors: focus on fluvoxamine.
    Hrdina PD
    J Psychiatry Neurosci; 1991 Jul; 16(2 Suppl 1):10-8. PubMed ID: 1931931
    [No Abstract]   [Full Text] [Related]  

  • 40. Depression and serotonin metabolism: rationale for neurotransmitter precursor treatment.
    Byerley WF; Risch SC
    J Clin Psychopharmacol; 1985 Aug; 5(4):191-206. PubMed ID: 2410463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.